article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The post The rise of prescription drug abuse and drug diversion appeared first on.

article thumbnail

Corporations: “get healthcare costs under control”

World of DTC Marketing

According to data from KFF’s annual survey of employers , between 2010 and 2020, insurance premiums for employer-sponsored family coverage rose by 55 percent; the employer’s contribution went up 61 percent. It’s going to affect every sector of healthcare, from prescription drugs to hospitals, and is going to squeeze profit margins.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The future of pain medication: are cannabinoids the solution to the opioid epidemic?

Pharmaceutical Technology

Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010. In 2022, Pfizer acquired the drug, with the promise of accelerating clinical development via new, differentiated, and best-in-class approaches, enhancing optimism for further drug development.

Medical 143
article thumbnail

ELITE 2023 Sales MVP Laura Blair of ConnectiveRx

PM360

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura is not shy about sharing her cancer experience. Laura has educated the new ConnectiveRx employees on the “real” patient journey.

Sales 94
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. The MA pathway is applicable for herbal medicines designed to treat more serious health conditions and require a medical prescription or the supervision of a medical practitioner. 2010 [cited 2024May].

Marketing 103
article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. Food and Drug Administration between 2010 and 2016 yet did taxpayers receive any discount? Centene Corp.,

article thumbnail

Navigating the Challenges of Biopharma Product Launches: A Blueprint for Success

PM360

The landscape is highly competitive with new prescription medications launching worldwide each year. Embarking on the journey from product development to market success in the biopharma industry is no small feat. However, this journey is fraught with challenges as revealed by an in-depth analysis.